Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

Objectives: On January 18, 2010, a part of the capital region of Denmark shifted the empirical treatment of febrile conditions from cefuroxime to piperacillin/tazobactam. We compare empirical treatment with piperacillin/tazobactam versus cefuroxime for Escherichia coli bacteremia with regard to 14 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Thønnings, Sara, Jansåker, Filip, Gradel, Kim Oren, Styrishave, Bjarne, Knudsen, Jenny Dahl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526191/
https://www.ncbi.nlm.nih.gov/pubmed/31190913
http://dx.doi.org/10.2147/IDR.S197735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526191/
https://www.ncbi.nlm.nih.gov/pubmed/31190913
http://dx.doi.org/10.2147/IDR.S197735

Ejemplares similares